ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 78 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $316,000 | +75.6% | 59,771 | +59.4% | 0.00% | – |
Q1 2021 | $180,000 | +14.6% | 37,492 | +3.7% | 0.00% | – |
Q4 2020 | $157,000 | -35.4% | 36,150 | -38.7% | 0.00% | – |
Q3 2020 | $243,000 | +60.9% | 58,990 | +0.0% | 0.00% | – |
Q2 2020 | $151,000 | -11.2% | 58,963 | 0.0% | 0.00% | – |
Q1 2020 | $170,000 | -23.8% | 58,963 | 0.0% | 0.00% | – |
Q4 2019 | $223,000 | -68.6% | 58,963 | -57.5% | 0.00% | -100.0% |
Q3 2019 | $710,000 | -17.4% | 138,724 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $860,000 | -53.8% | 138,724 | -41.6% | 0.00% | 0.0% |
Q1 2019 | $1,862,000 | +79.6% | 237,478 | +95.5% | 0.00% | 0.0% |
Q4 2018 | $1,037,000 | -56.2% | 121,459 | +2.8% | 0.00% | -66.7% |
Q3 2018 | $2,365,000 | -37.4% | 118,117 | -19.2% | 0.00% | -40.0% |
Q2 2018 | $3,775,000 | +333.4% | 146,129 | +301.1% | 0.01% | +400.0% |
Q1 2018 | $871,000 | -29.5% | 36,431 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $1,235,000 | +59.8% | 36,431 | -0.2% | 0.00% | +100.0% |
Q3 2017 | $773,000 | – | 36,506 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |